Piramal Pharma Limited has submitted a regulatory filing to both BSE Limited and National Stock Exchange of India Limited regarding the availability of the transcript from their quarterly earnings conference call.
The disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and serves as a continuation of their previous communication dated 16th October, 2026.
The conference call was conducted on 28th October, 2026, to discuss the company's unaudited financial results, both on a standalone and consolidated basis, for the quarter and half year ended 30th September, 2026.
The complete transcript of this earnings conference call has been made available on the company's official website at https://www.piramalpharma.com/financial-reports.
The document was digitally signed by Maneesh Sharma, who holds the position of Company Secretary & Compliance Officer at Piramal Pharma Limited, on 30th October, 2026 at 14:49:43 IST.